4896

K Pharma,Inc.

株式会社ケイファーマ
Pharmaceutical
K Pharma,Inc. engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan. It develops regenerative medicine products using disease-specific induced pluripotent stem (iPS) cell technology for spinal cord injuries and cerebral infarctions. The company was incorporated in 2016 and is headquartered in Minato, Japan.
← Companies
Price
¥704
Market Cap
¥8.2B
Ent. Value
¥6.9B
Net Cash
¥1.3B
Shares Out.
11.6M
P / E
—
EV / EBIT
—
P / Book
6.46×
P / NCAV
6.72×
Div. Yield
—
Financials
Metric FY 2025
EDINET ↗ 		FY 2024
EDINET ↗ 		FY 2023
EDINET ↗
Net Sales — — ¥1.0B
Cost of Sales — — ¥90M
Gross Profit — — ¥910M
SG&A ¥916M ¥836M ¥544M
Operating Income ¥-916M ¥-836M ¥366M
Non-Operating Income ¥3M ¥1M ¥0M
Interest Income ¥3M ¥0M ¥0M
Non-Operating Expenses ¥7M ¥1M ¥22M
Interest Expense ¥1M — —
Ordinary Income ¥-921M ¥-836M ¥344M
Pre-tax Income ¥-990M ¥-844M ¥301M
Income Taxes ¥3M ¥2M ¥41M
Current Tax ¥3M ¥2M ¥41M
Net Income (owners) ¥-993M ¥-846M ¥260M
EPS ¥-85.59 ¥-72.94 ¥25.42
Shares Outstanding 11.6M 11.6M 11.6M
Shares Issued (total) 11.6M 11.6M 11.6M